ArticleBlood2026

Off-the-shelf dual CAR-iNKT cell immunotherapy eradicates medullary and leptomeningeal high-risk KMT2A-rearranged leukemia.

Hongwei Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.